According to new clinical trial results, there is evidence that a high-dose immunosuppressive therapy followed by the transplantation of stem cells that form blood can trigger sustainable suspension of relapsing-remitting multiple sclerosis, which is a disease that causes the immune system to strike the central nervous system. After receiving the treatment called autologous hematopoietic cell transplant and high-dose immunosuppressive therapy (HCT/HDIT) for five years, about 69 percent of patients on trial survived without encountering advancement of disability, deterioration of MS symptoms or even advanced brain lesions. After receiving HCT/HDIT, the participants did not take any MS medication.
The National Institute of Allergy and Infectious Disease sponsored a trial referred to as HALT-MS. The experimental treatment aims at suppressing the disease that is active and preventing any further disability. This is achievable by getting rid of the cells that cause disease as well as resetting the immune system. In this procedure, the doctors collect blood-forming stem cells from the participants, give the patients a high-dose of chemotherapy so as to deplete the immune system then later return the members’ stem cell to reconstruct the immune system.
Neurologists play a vital part in all this. One of such is Shiva Gopal Vasishta. He practices in Voorhees. He is a graduate of the Government Medical College. He has been practicing for close to 40 years after graduating in the year 1979. He has diverse experience in the field and as such is an expert in Neurology. Shiva Gopal Vasishta is closely associated with Kennedy University Hospital and is among the 34 neurologists practicing at the institution.
Shiva Gopal Vasishta finished a residency at Boston City Hospital. Dr. Shiva Gopal Vasishta accepts various insurance plans that include Horizon Blue Cross Blue Shield Medicare, as well as Aetna Shiva Gopal Vasishta, is certified by the board in Neurology. Besides English, Shiva Gopal Vasishta can practice in Spanish.